VitaSpring Biomedical Co. Ltd.
VSBC
$1.00
$0.000.00%
OTC PK
| 10/31/2022 | 07/31/2022 | 04/30/2022 | 01/31/2022 | 10/31/2021 | |
|---|---|---|---|---|---|
| Net Income | -34.01% | -175.76% | 17.39% | 372.32% | -459.58% |
| Total Depreciation and Amortization | 0.00% | 375.00% | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 202.04% | -128.49% | 611.37% | -11.38% | -- |
| Change in Net Operating Assets | 137.41% | 418.41% | -388.57% | -1,032.37% | -900.35% |
| Cash from Operations | 100.66% | -122.19% | -107.83% | -265.50% | -- |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -45.05% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | -- | -- | -42.86% | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 100.63% | -127.45% | -107.83% | -338.93% | -- |